D. Hirth

Does dexamethasone inhibit anticancer activity of cetuximab in squamous cell carcinoma cell lines of the head and neck?

M. Hambek, M. Baghi, W. Gstöttner, 2009, Oncology reports.

Antitumoral effect of PLK-1-inhibitor BI2536 in combination with cisplatin and docetaxel in squamous cell carcinoma cell lines of the head and neck.

M. Leinung, T. Stöver, M. Hambek, 2013, Molecular and clinical oncology.

Antitumoral effect of PLK1-inhibitor BI 2536 in combination with cisplatin and docetaxel in squamous cell carcinoma cell lines of the head and neck

M. Leinung, T. Stöver, M. Hambek, 2013 .

Effects of the Polo-like-kinase-1-inhibitor BI2536 in squamous cell carcinoma cell lines of the head and neck.

T. Stöver, M. Hambek, J. Wagenblast, 2012, Oncology letters.

Randomized controlled single‐blinded clinical trial of functional voice outcome after vascular targeting KTP laser microsurgery of early laryngeal cancer

J. Künzel, S. Strieth, Katharina Eder, 2019, Head & neck.

A new adhesive bone conduction hearing system as a treatment option for transient hearing loss after middle ear surgery

Martin Leinung, Timo Stöver, Silke Helbig, 2019, European Archives of Oto-Rhino-Laryngology.

[Penetration-Aspiration Scale according to Rosenbek. Validation of the German version for endoscopic dysphagia diagnostics].

T. Stöver, C. Hey, P. Pluschinski, 2014, HNO (Berlin. Print).

Fighting cancer from different signalling pathways: Effects of the proteasome inhibitor Bortezomib in combination with the polo-like-kinase-1-inhibitor BI2536 in SCCHN.

M. Leinung, T. Stöver, J. Wagenblast, 2012, Oncology letters.